Accordingly, the scRNA+TCRαβ-seq data confirmed that the expanded pre-REP TIL clonotypes mostly encompassed a CD8+ TEXH-cell phenotype in the original tumor samples, whereas the most expanded REP TIL clonotypes originate from tumor CD4+ TCYTOTOXIC cells. The gene discussed is CD4; the disease is neoplasm.